Cardio-Oncology

Management of Toxicities in the Era of Immunotherapy

Häftad, Engelska, 2023

AvAntonio Russo,Nicola Maurea,Dimitrios Farmakis,Antonio Giordano

1 429 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

In recent years, new immunotherapies have been studied and approved in a growing number of tumors including melanoma, non-small cell lung cancer (NSCLC), and renal cell cancer (RCC). This volume provides a complete and updated state-of-art review regarding the management of cardiovascular toxicities from new immunotherapies.

Produktinformation

Utgivningsdatum2023-08-10
Mått155 x 235 x 8 mm
Vikt243 g
FormatHäftad
SpråkEngelska
SerieCurrent Clinical Pathology
Antal sidor122
FörlagSpringer Nature Switzerland AG
ISBN9783030977467

Tillhör följande kategorier

Onkologi inom Medicin
Klinisk medicin och internmedicin inom Medicin
Hjärt- och kärlsjukdomar inom Medicin
Patologi inom Medicin

Antonio Russo, MDDepartment of Oncology - A.O.U.P. "P. Giaccone" University Hospital. Via del Vespro 129, CAP 90127 Palermo, Italy. Email: antonio.russo@usa.net Nicola Maurea, MDDivision of Cardiology, Istituto Nazionale Tumori⁻IRCCS-Fondazione G.PascaleVia Mariano Semmola, 52 80131 Napoli, Italy. Email: nicolamaurea@virgilio.it Dimitrios Farmakis, MD, PhD, FESC, FHFAAssoc. Professor, University of Cyprus Medical SchoolShacolas Educational Centre for Clinical Medicine, 215 Palaios dromos Lefkosias Lemesou, 2029, Nicosia, CyprusVisiting Professor, National and Kapodistrian University of Athens Medical SchoolAthens University Hospital Attikon, 1 Rimini St, 12462, Athens, GreeceEmail: farmakis.dimitrios@ucy.ac.cy; dimitrios_farmakis@yahoo.com Antonio Giordano, MDSbarro Institute for Cancer Research and Molecular Medicine and Center of BiotechnologyCollege of Science and Technology, Temple University200 Tuttleman Learning Center 1809 N 13th Street Philadelphia, 19122 USA. Email: giordano@temple.edu

1. Background: Immunology and cancer.- 2. Available immunotherapy drugs in oncology.- 3. Immunotherapy adverse events.- 4. Pathophysiology of cardiac toxicity.- 5. Cardiac risk factors for immunotherapy.- 6. Diagnostic methods of cardiac immunotherapy damaging.- 7. Biomarkers of early cardiotoxicity.- 8. Management of Patients with Cardiac Toxicity: the point of view of the cardiologist.- 9. Management of patients with cardiac toxicity: the point of view of the oncologist.- 10. Future perspectives.